Clinical and cell kinetic studies of the effects of the epipodophyllotoxin VP16-213 during therapy of refractory acute nonlymphocytic leukemia
- 1 April 1982
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 7 (2-3) , 161-167
- https://doi.org/10.1007/bf00254540
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- EFFECTIVE REMISSION INDUCTION OF REFRACTORY CHILDHOOD ACUTE NONLYMPHOCYTIC LEUKEMIA BY VP-16-213 PLUS AZACITIDINE1981
- Treatment of Acute Myelogenous Leukemia in Children and AdultsNew England Journal of Medicine, 1980
- A SIMPLIFIED METHOD OF DNA DISTRIBUTION ANALYSISCell Proliferation, 1980
- Multi-user system for analysis of data from flow cytometryComputer Programs in Biomedicine, 1979
- Advances in the Treatment of Acute Myelogenous LeukemiaNew England Journal of Medicine, 1979
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976
- SURVIVAL AND CYCLE-PROGRESSION DELAY OF HUMAN LYMPHOMA-CELLS INVITRO EXPOSED TO VP-16-2131976
- Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts.The Journal of cell biology, 1975
- 4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations.1975
- Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.The Journal of cell biology, 1975